Helvetic BioPharma, a pioneering biopharmaceutical firm based in Switzerland, specializes in producing biosimilar recombinant proteins, artificial peptides, and monoclonal antibodies for therapeutic applications. The company focuses on various therapeutic areas such as oncology, hematology, immuno-modulation, and auto-immune diseases